The relationship between prognosis and CEA-dt after hepatic resection in patients with colorectal carcinomas

European Journal of Surgical Oncology

Volumn 25, Issue 3, 1999, Pages 292-296

  Koga, H ^a   Moriya, Y ^a   Akasu, T ^a   Fujita, S ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Carcinoembryonic antigen; CEA doubling time; Colorectal cancer; Hepatic resection

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; ARTICLE; BLOOD LEVEL; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL FEATURE; COLORECTAL CANCER; COMPARATIVE STUDY; CORRELATION FUNCTION; HUMAN; HUMAN CELL; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS;

EID: 0033153158     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.1998.0644     Document Type: Article

References (14)

1. Foster JM. Survival after resection for secondary tumors. Am J Surg 1978; 135: 389-94.
2. Collins VP, Loeffler RK, Tiver H. Observation on growth rates of human tumors. Am J Roentgenol 1956; 76: 988-1000.
3. Collins VP. Time of occurrence of pulmonary metastases from carcinoma of colon and rectum. Cancer 1962; 15: 387-95.
4. Staab HJ, Andre FA, Hornung A, Stumpf E, Fischer R. Doubling time of circulating CEA and its relation to survival of patients with recurrent colorectal cancer. Br J Cancer 1982; 46: 773-81.
5. Yamamoto J, Sugihara K, Kosuge T, Takayama T, Shimada K, Yamasaki S, Sakamoto M, Hirohashi S. Pathologic support for limited hepatectomy in the treatment of liver metastasis from colorectal cancer. Ann Surg 1995; 219: 74-8.
6. Gold P, Freeman SO. Specific carcinoembryonic antigens of the human digestive system. J Exp Med 1965; 122: 467-81.
7. Gold P, Freeman SO. Demonstration of tumor-specific antigens in human colonie carcinoma by immunological tolerance and absorption techniques. J Exp Med 1965; 121: 439-62.
8. Wanebo HJ, Rao B, Pinsky CM, Hoffman RG, Stearns M, Schwartz MK, Oettgen HF. Preoperative carcioembryogenic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med 1978; 299: 448-51.
9. Mach JP, Jaeger P, Berthlet MM, Ruegsegger CH, Loosli RM, Pettavel J. Detection of recurrence of large bowel carcinoma by radioimmunoassay of circulating carcinoembryonic antigen (CEA). Lancet 1974; 2: 535-40.
10. Umehara Y, Kimura T, Yoshida M, Oba N, Harada Y. Comparison of doubling times of serum carcinoembryonic antigen produced by various metastasis lesion in recurrent gastric and colorectal carcinoma. Cancer 1993; 71: 4055-9.
11. Wood CB, Ratcliffe JG, Burt RW, Malcolm AJH, Blumgart LH. The clinical significance of the pattern of elevated serum carcinoembryonic antigen (CEA) levels in recurrent colorectal cancer. Br J Surg 1980; 67: 46-8.
12. Dennis J, Ahnen P, Nakane K, Brwon WR. Ultrastructural localization of carcinoembryonic antigen in normal intestine and colon cancer. Cancer 1982; 49: 2077-90.
13. Korenaga D, Saeki H, Mawatari K, Orita H, Maekawa S, Ikeda T, Sugimachi K. Serum carcinoembryonic antigen concentration doubling time correlates with tumor biology and life expectancy in patients with recurrent gastrointestinal carcinoma. Arch Surg 1997; 132: 188-94.
14. Moriya Y, Sugihara K, Hojo K, Makuuchi M. Adjuvant hepatic intra-arterial chemotherapy after potentially curative hepatectomy for liver metastasis from colorectal cancer: A pilot study. Eur J Surg Oncol 1991; 17: 519-25.